Answers are grounded in this paper and cite their sources.
A 71-y-old woman with primary hyperparathyroidism underwent 99mTc-sestamibi SPECT/CT for preoperative localization. The study showed a left inferior parathyroid adenoma and, on extended field-of-view review, an intensely 99mTc-sestamibi–avid 1.5-cm lesion in the left breast. Diagnostic mammography and ultrasonography classified the lesion as Breast Imaging Reporting and Data System category 5, prompting a core biopsy that revealed Nottingham grade 3 invasive ductal carcinoma of no special type (human epidermal growth factor receptor 2 [HER2] overexpression [3+]), with a Ki-67 index of 80%. After sentinel lymph node mapping, the patient underwent wide local excision and sentinel lymph node biopsy. Final pathology demonstrated a 1.9-cm grade 3 carcinoma with associated ductal carcinoma in situ and a 1-mm nodal micrometastasis identified in a sentinel lymph node. She completed adjuvant chemotherapy, radiotherapy, and HER2-targeted therapy, with no recurrence at 2-y follow-up. This case emphasizes deliberate review of the complete hybrid SPECT/CT field of view during parathyroid imaging.
No takes yet. Share an insight, caveat, or question.
Elmakki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: